Milestone Pharmaceuticals Inc.
MIST
$1.51
-$0.13-7.67%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 28.30% | 90.21% | -22.41% | -19.71% | -8.80% |
| Total Receivables | 142.27% | 8.46% | -10.22% | -13.40% | -13.59% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -29.96% | 244.52% | -68.25% | 28.04% | -27.07% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -91.02% | -0.89% | 0.00% | 1,004.92% |
| Total Current Assets | 29.13% | 87.73% | -23.66% | -18.20% | -8.72% |
|
|
|||||
| Total Current Assets | 29.13% | 87.73% | -23.66% | -18.20% | -8.72% |
| Net Property, Plant & Equipment | 51.85% | -13.53% | -11.42% | -10.36% | -8.33% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 29.41% | 85.06% | -23.38% | -18.03% | -8.71% |
|
|
|||||
| Total Accounts Payable | 77.35% | 8.71% | 22.82% | 23.40% | 18.45% |
| Total Accrued Expenses | -7.52% | 17.43% | -41.82% | 78.50% | 84.66% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 33.95% | -6.21% | -4.98% | -5.08% | -1.89% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 32.83% | 13.37% | -28.39% | 59.52% | 54.55% |
|
|
|||||
| Total Current Liabilities | 32.83% | 13.37% | -28.39% | 59.52% | 54.55% |
| Long-Term Debt | 1.75% | 1.75% | 1.75% | 1.75% | 1.75% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 3.85% | -19.03% | -15.44% | -13.27% | -12.77% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 6.76% | 3.20% | -4.18% | 9.07% | 6.23% |
|
|
|||||
| Common Stock & APIC | 10.23% | 14.40% | 0.41% | 0.46% | 0.46% |
| Retained Earnings | -4.21% | -2.97% | -3.34% | -5.65% | -3.48% |
| Treasury Stock & Other | 0.00% | 4.85% | 0.00% | 0.00% | 0.00% |
| Total Common Equity | 103.74% | 215.53% | -189.81% | -146.57% | -45.25% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 103.74% | 215.53% | -189.81% | -146.57% | -45.25% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 103.74% | 215.53% | -189.81% | -146.57% | -45.25% |
|
|
|||||